LIN7A (lin-7 cell polarity scaffold A) is a membrane-associated scaffold protein that plays a crucial role in establishing and maintaining cell polarity, particularly in epithelial cells and neurons. The protein forms multiprotein complexes that regulate the asymmetric distribution of channels and receptors at plasma membranes, ensuring proper localization of proteins like NMDA receptor subunits, Kir2 channels, and EGFR family members to specific membrane domains 1. In cancer contexts, LIN7A demonstrates significant clinical relevance across multiple tumor types. In glioblastoma, LIN7A functions as a tumor suppressor where its silencing promotes cell invasion through disruption of intercellular junctions and activation of the β-catenin pathway 2. Conversely, in breast carcinomas, particularly invasive micropapillary carcinomas (IMPCs), LIN7A overexpression drives hyperproliferation, invasion, and polarity defects, representing a major determinant of cell-polarity abnormalities 3. The protein also serves as a therapeutic biomarker in t(8;21) acute myeloid leukemia, where hypermethylated LIN7A correlates with poor clinical outcomes and its restoration through decitabine treatment improves therapeutic responses 4. Additionally, LIN7A expression levels have been associated with idiopathic pulmonary fibrosis and bone non-union, suggesting broader roles in tissue homeostasis and repair processes 56.